The Efficacy and Safety of Regorafenib in Combination With Anti-PD-1 Antibody in Refractory Microsatellite Stable Metastatic Colorectal Cancer: A Retrospective Study

Cited by papers we hold 3

• PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies · 2023
  No notice
• Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier · 2022
  No notice
• Cancer combination therapies by angiogenesis inhibitors; a comprehensive review · 2022
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.